Motley Fool Wealth Management, LLC Biomarin Pharmaceutical Inc Transaction History

Motley Fool Wealth Management, LLC

$1.8 Billion
Q4 2024

A detailed history of Motley Fool Wealth Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Motley Fool Wealth Management, LLC holds 347,728 shares of BMRN stock, worth $23.7 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares

347,728

Previous 424,597 18.1%

Holding current value

$23.7 Million

Previous $29.8 Million 23.42%

% of portfolio

1.27%

Previous 1.59%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$61.93 - $70.49 $4.76 Million - $5.42 Million	-76,869 Reduced 18.1%	347,728 $22.9 Million
Q3 2024 Nov 14, 2024	SELL	$69.02 - $93.84 $1.46 Million - $1.98 Million	-21,106 Reduced 4.74%	424,597 $29.8 Million
Q2 2024 Aug 08, 2024	SELL	$74.43 - $92.22 $969,971 - $1.2 Million	-13,032 Reduced 2.84%	445,703 $36.7 Million
Q1 2024 May 08, 2024	SELL	$83.81 - $99.0 $968,340 - $1.14 Million	-11,554 Reduced 2.46%	458,735 $40.1 Million
Q4 2023 Feb 02, 2024	SELL	$76.22 - $98.51 $1.42 Million - $1.84 Million	-18,667 Reduced 3.82%	470,289 $45.3 Million
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $13.6 Million - $15.1 Million	159,421 Added 48.38%	488,956 $43.3 Million
Q2 2023 Aug 09, 2023	SELL	$86.68 - $100.3 $630,250 - $729,281	-7,271 Reduced 2.16%	329,535 $28.6 Million
Q1 2023 May 10, 2023	SELL	$87.74 - $117.27 $161,090 - $215,307	-1,836 Reduced 0.54%	336,806 $32.8 Million
Q4 2022 Feb 09, 2023	SELL	$80.93 - $108.63 $343,709 - $461,351	-4,247 Reduced 1.24%	338,642 $35 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $501,176 - $591,334	-6,100 Reduced 1.75%	342,889 $29.1 Million
Q2 2022 Aug 11, 2022	SELL	$71.48 - $86.85 $571,911 - $694,886	-8,001 Reduced 2.24%	348,989 $28.9 Million
Q1 2022 May 04, 2022	BUY	$74.28 - $92.69 $9.57 Million - $11.9 Million	128,822 Added 56.46%	356,990 $27.5 Million
Q4 2021 Feb 10, 2022	SELL	$71.72 - $91.47 $396,970 - $506,286	-5,535 Reduced 2.37%	228,168 $20.2 Million
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $508,959 - $581,794	-6,807 Reduced 2.83%	233,703 $18.1 Million
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $287,768 - $323,134	-3,811 Reduced 1.56%	240,510 $20.1 Million
Q1 2021 May 11, 2021	SELL	$74.73 - $90.69 $191,308 - $232,166	-2,560 Reduced 1.04%	244,321 $18.4 Million
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $130,117 - $161,638	1,792 Added 0.73%	246,881 $21.6 Million
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $109,817 - $200,213	1,528 Added 0.63%	245,089 $18.6 Million
Q2 2020 Aug 12, 2020	SELL	$79.55 - $124.22 $571,805 - $892,893	-7,188 Reduced 2.87%	243,561 $30 Million
Q1 2020 May 13, 2020	SELL	$71.37 - $96.85 $892,910 - $1.21 Million	-12,511 Reduced 4.75%	250,749 $21.2 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $16.9 Million - $22.7 Million	263,260 New	263,260 $22.3 Million

Others Institutions Holding BMRN

# of Institutions

626

Shares Held

183M

Call Options Held

Put Options Held

1.67M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.7B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Motley Fool Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motley Fool Wealth Management, LLC with notifications on news.

Account

Motley Fool Wealth Management, LLC Biomarin Pharmaceutical Inc Transaction History